Autoregulated splicing of TRA2 β programs T cell fate in response to antigen-receptor stimulation
Timofey A. Karginov,Antoine Ménoret,Nathan K. Leclair,Andrew G. Harrison,Karthik Chandiran,Jenny E. Suarez-Ramirez,Marina Yurieva,Keaton Karlinsey,Penghua Wang,Rachel J. O'Neill,Patrick A. Murphy,Adam J. Adler,Linda S. Cauley,Olga Anczuków,Beiyan Zhou,Anthony T. Vella
DOI: https://doi.org/10.1126/science.adj1979
IF: 56.9
2024-09-14
Science
Abstract:T cell receptor (TCR) sensitivity to peptide–major histocompatibility complex (MHC) dictates T cell fate. Canonical models of TCR sensitivity cannot be fully explained by transcriptional regulation. In this work, we identify a posttranscriptional regulatory mechanism of TCR sensitivity that guides alternative splicing of TCR signaling transcripts through an evolutionarily ultraconserved poison exon (PE) in the RNA-binding protein (RBP) TRA2β in mouse and human. TRA2 β - PE splicing, seen during cancer and infection, was required for TCR-induced effector T cell expansion and function. Tra2 β-PE skipping enhanced T cell response to antigen by increasing TCR sensitivity. As antigen levels decreased, Tra2 β-PE reinclusion allowed T cell survival. Finally, we found that TRA2 β-PE was first included in the genome of jawed vertebrates that were capable of TCR gene rearrangements. We propose that TRA2 β - PE splicing acts as a gatekeeper of TCR sensitivity to shape T cell fate.
multidisciplinary sciences